EMILIE MATHIAS: Open Payments
NPI 1659983856 · DECATUR, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$720 in 33 payments from 12 companies in 2025. Trend: 2023 $1,213 · 2024 $1,236 · 2025 $720
Food & beverage: $720
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 10 | $230 |
| Amgen Inc. | 4 | $86 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $77 |
| AstraZeneca Pharmaceuticals LP | 4 | $74 |
| Esperion Therapeutics, Inc. | 3 | $66 |
| Novo Nordisk Inc | 2 | $42 |
| Boston Scientific Corporation | 1 | $39 |
| Vital Connect, Inc | 1 | $29 |
| HEARTFLOW, INC. | 1 | $24 |
| ABIOMED | 1 | $22 |
Products named: LEQVIO, REPATHA, JARDIANCE, NEXLETOL, Wegovy, BodyGuardian, VITALPATCH RTM, FFRct.
Industry payments across GA — which companies pay providers there.
